Infection Prevention and Control
Showing 1 - 25 of >10,000
Tuberculosis, Latent Tuberculosis Infection Trial in Bijie, Linping, Qingzhen (QuantiFERON-TB Gold (QFT) test)
Recruiting
- Tuberculosis
- Latent Tuberculosis Infection
- QuantiFERON-TB Gold (QFT) test
-
Bijie, Guizhou, China
- +4 more
Sep 12, 2023
Hospital-acquired Infections Trial (Infection prevention and control (IPC))
Not yet recruiting
- Hospital-acquired Infections
- Infection prevention and control (IPC)
- (no location specified)
Nov 26, 2022
Covid-19, Nosocomial Infection, Coronavirus Trial in London (Use of virus (Covid-19) genome sequence report to inform infection
Completed
- Covid-19
- +4 more
- Use of virus (Covid-19) genome sequence report to inform infection prevention control procedures
-
London, United KingdomUniversity College London Hospitals NHS Foundation Trust
Feb 16, 2022
Surgical Site Infection, Cesarean Section; Infection Trial in Pittsburgh (2% Chlorhexidine gluconate with 70% alcohol, 4%
Not yet recruiting
- Surgical Site Infection
- Cesarean Section; Infection
- 2% Chlorhexidine gluconate with 70% alcohol
- 4% Chlorhexidine Gluconate aqueous solution
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Jun 15, 2023
HPV InfectioN, HPV-Related Carcinoma Trial in China (Recombinant 14-Valent Human Papillomavirus Vaccine(Insect Cell), )
Active, not recruiting
- HPV InfectioN
- HPV-Related Carcinoma
- Recombinant 14-Valent Human Papillomavirus Vaccine（Insect Cell）
- placebo
-
Nanning, Guangxi, China
- +4 more
Sep 10, 2023
Gastroscopy, Esophagogastroduodenoscopy, Equipment Design Trial in Roma, Rotterdam (Single-use gastroscope)
Recruiting
- Gastroscopy
- +6 more
- Single-use gastroscope
-
Roma, Italy
- +1 more
Aug 16, 2022
Vaccination; Infection, Influenza Trial in Dongguang (Health education)
Recruiting
- Vaccination; Infection
- Influenza
- Health education
-
Dongguang, Guangdong, ChinaDongguang Center for Disease Control and Prevention
Sep 20, 2023
Streptococcus Pneumoniae Infection Trial in China (13-valent pneumococcal conjugate vaccine (multivalent conjugate), Prevenar
Recruiting
- Streptococcus Pneumoniae Infection
- 13-valent pneumococcal conjugate vaccine (multivalent conjugate)
- Prevenar 13
-
Hechi City, Guangxi Zhuang Autonomous Region, China
- +4 more
Feb 26, 2023
Surgical Site Infection, Cesarean Section; Complications, Wound, Infection (Following Delivery), Postpartum Complication Trial
Not yet recruiting
- Surgical Site Infection
- +2 more
- Steri3X
- Control
- (no location specified)
May 22, 2022
Hiv, HIV, Sexually Transmitted Infection Trial in Miami, Ann Arbor (Intervention LuvHub, Waitlist Control LuvHub)
Recruiting
- Hiv
- +5 more
- Intervention LuvHub
- Waitlist Control LuvHub
-
Miami, Florida
- +1 more
Jan 23, 2023
C. Difficile Trial (Arm 1: Routine care, Arm 2: Preemptive C. difficile infection prevention bundle)
Recruiting
- C. Difficile
- Arm 1: Routine care
- Arm 2: Preemptive C. difficile infection prevention bundle
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 23, 2022
SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)
Recruiting
- SARS-CoV-2 Infection
- COVID-19 mRNA Vaccine (ZSVG-02-O)
- COVID-19 Vaccine (Vero Cell) ,Inactivated
-
Dengfeng, Henan, China
- +1 more
Nov 6, 2023
Human Papillomavirus Infection Trial in Kunming (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus
Active, not recruiting
- Human Papillomavirus Infection
- Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
- GARDASIL® 9
-
Kunming, Yunnan, ChinaYunnan Center for Disease Prevention and Control
Dec 23, 2022
Infection Prevention and Control Practices Regarding COVID-19
Completed
- COVID-19 Pandemic
- Questionnaire
-
Riyadh, Saudi ArabiaKing Saud University
Nov 19, 2021
HIV Trial in Chennai, Tamil Nadu (psychoeducational, control)
Withdrawn
- HIV Infections
- psychoeducational
- control
-
Chennai, Tamil Nadu, IndiaYRG Care
Sep 19, 2022
Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Hepatitis E Virus Infection Trial in Hanzhou
Active, not recruiting
- Human Papilloma Virus Infection Type 16
- +2 more
- Cecolin
- Hecolin
-
Hanzhou, Zhejiang, ChinaZhejiang Provincial Center for Disease Control and Prevention
Jun 8, 2022
HCV Care and Treatment for HIV-HCV Co-infected Decentralised
Not yet recruiting
- HIV Infection
- Hepatitis C Infection
- Blood samples
-
Vinh, Nghe An, Vietnam
- +1 more
Aug 16, 2022
HPV InfectioN, HPV-Related Carcinoma Trial in China (11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha),
Recruiting
- HPV InfectioN
- HPV-Related Carcinoma
- 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha)
- placebo
-
Hechi, Guangxi, China
- +7 more
Jun 5, 2022
Sexually Transmitted Infection, Hiv Trial in Cape Town (IMARA-SA (intervention group), Health promotion control group)
Completed
- Sexually Transmitted Infection
- Hiv
- IMARA-SA (intervention group)
- Health promotion control group
-
Cape Town, Western Cape, South AfricaDesmond Tutu HIV Centre
Aug 15, 2022
Evaluation of HIV-1 Recent Infection Testing in Rwanda
Recruiting
- HIV Infections
- Return of recent classification
- Return of long-term classification
-
Kigali, RwandaRwanda Biomedical Centre, Ministry of Health
May 9, 2022
HPV Vaccination on HPV Infection and Cervical Related Disease
Not yet recruiting
- HPV Infection
- Cervical Disease
- Questionnaire Survey and Cervical Cancer Screening
- (no location specified)
Apr 24, 2022
Drug Exposure and Minimum Inhibitory Concentration in Treatment
Not yet recruiting
- Mycobacterium Avium Complex
- +3 more
- Drug exposure
-
Shanghai, ChinaShanghai Pulmonary Hospital
Apr 10, 2023
COVID-19 Respiratory Infection, SARS-CoV-2 Acute Respiratory Disease Trial in Pamplona (Nasal Photodisinfection, Sham
Completed
- COVID-19 Respiratory Infection
- SARS-CoV-2 Acute Respiratory Disease
- Nasal Photodisinfection
- Sham Comparator: Control
-
Pamplona, SpainClinica Universidad de Navarra
Aug 10, 2022
HIV, HIV/AIDS, Neisseria Gonorrheae Infection Trial in Kisumu (Doxycycline)
Active, not recruiting
- HIV Infections
- +4 more
-
Kisumu, KenyaKenya Medical Research Institute
Feb 21, 2022
Cervical Intraepithelial Neoplasia, Cervical Cancer, Vaginal Intraepithelial Neoplasia Trial in Dongtai (Recombinant Human
Completed
- Cervical Intraepithelial Neoplasia
- +4 more
- Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) / Cecolin®
-
Dongtai, Jiangsu, ChinaDongtai City Center for Disease Control and Prevention Dongtai,
Jun 22, 2022